These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
208 related items for PubMed ID: 22970326
1. Notch activation is dispensable for D, L-sulforaphane-mediated inhibition of human prostate cancer cell migration. Hahm ER, Chandra-Kuntal K, Desai D, Amin S, Singh SV. PLoS One; 2012; 7(9):e44957. PubMed ID: 22970326 [Abstract] [Full Text] [Related]
2. Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration. Kim SH, Sehrawat A, Sakao K, Hahm ER, Singh SV. PLoS One; 2011; 6(10):e26615. PubMed ID: 22039516 [Abstract] [Full Text] [Related]
3. Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration. Kim SH, Sehrawat A, Singh SV. Breast Cancer Res Treat; 2012 Aug; 134(3):1067-79. PubMed ID: 22476855 [Abstract] [Full Text] [Related]
4. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells. Kim SH, Singh SV. Mol Cancer Ther; 2009 Jul; 8(7):1946-54. PubMed ID: 19584240 [Abstract] [Full Text] [Related]
5. D,L-Sulforaphane-induced cell death in human prostate cancer cells is regulated by inhibitor of apoptosis family proteins and Apaf-1. Choi S, Lew KL, Xiao H, Herman-Antosiewicz A, Xiao D, Brown CK, Singh SV. Carcinogenesis; 2007 Jan; 28(1):151-62. PubMed ID: 16920735 [Abstract] [Full Text] [Related]
6. Functional relevance of D,L-sulforaphane-mediated induction of vimentin and plasminogen activator inhibitor-1 in human prostate cancer cells. Vyas AR, Singh SV. Eur J Nutr; 2014 Apr; 53(3):843-52. PubMed ID: 24092501 [Abstract] [Full Text] [Related]
7. Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells. Hahm ER, Singh SV. Cancer Prev Res (Phila); 2010 Apr; 3(4):484-94. PubMed ID: 20233902 [Abstract] [Full Text] [Related]
8. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Lee J, Sehrawat A, Singh SV. Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833 [Abstract] [Full Text] [Related]
9. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, Zeng Y, Watkins SC, Johnson CS, Trump DL, Lee YJ, Xiao H, Herman-Antosiewicz A. J Biol Chem; 2005 May 20; 280(20):19911-24. PubMed ID: 15764812 [Abstract] [Full Text] [Related]
10. Induction of p21 protein protects against sulforaphane-induced mitotic arrest in LNCaP human prostate cancer cell line. Herman-Antosiewicz A, Xiao H, Lew KL, Singh SV. Mol Cancer Ther; 2007 May 20; 6(5):1673-81. PubMed ID: 17513615 [Abstract] [Full Text] [Related]
11. Suppression of NF-kappaB and NF-kappaB-regulated gene expression by sulforaphane and PEITC through IkappaBalpha, IKK pathway in human prostate cancer PC-3 cells. Xu C, Shen G, Chen C, Gélinas C, Kong AN. Oncogene; 2005 Jun 30; 24(28):4486-95. PubMed ID: 15856023 [Abstract] [Full Text] [Related]
12. Targeting cell cycle machinery as a molecular mechanism of sulforaphane in prostate cancer prevention. Wang L, Liu D, Ahmed T, Chung FL, Conaway C, Chiao JW. Int J Oncol; 2004 Jan 30; 24(1):187-92. PubMed ID: 14654956 [Abstract] [Full Text] [Related]
13. Involvement of c-Jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by sulforaphane in DU145 prostate cancer cells. Cho SD, Li G, Hu H, Jiang C, Kang KS, Lee YS, Kim SH, Lu J. Nutr Cancer; 2005 Jan 30; 52(2):213-24. PubMed ID: 16201852 [Abstract] [Full Text] [Related]
14. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Carcinogenesis; 2004 Jan 30; 25(1):83-90. PubMed ID: 14514658 [Abstract] [Full Text] [Related]
15. Cellular responses to cancer chemopreventive agent D,L-sulforaphane in human prostate cancer cells are initiated by mitochondrial reactive oxygen species. Xiao D, Powolny AA, Antosiewicz J, Hahm ER, Bommareddy A, Zeng Y, Desai D, Amin S, Herman-Antosiewicz A, Singh SV. Pharm Res; 2009 Jul 30; 26(7):1729-38. PubMed ID: 19384467 [Abstract] [Full Text] [Related]
16. Reversal of the Warburg phenomenon in chemoprevention of prostate cancer by sulforaphane. Singh KB, Hahm ER, Alumkal JJ, Foley LM, Hitchens TK, Shiva SS, Parikh RA, Jacobs BL, Singh SV. Carcinogenesis; 2019 Dec 31; 40(12):1545-1556. PubMed ID: 31555797 [Abstract] [Full Text] [Related]
17. Differential effects of sulforaphane on histone deacetylases, cell cycle arrest and apoptosis in normal prostate cells versus hyperplastic and cancerous prostate cells. Clarke JD, Hsu A, Yu Z, Dashwood RH, Ho E. Mol Nutr Food Res; 2011 Jul 31; 55(7):999-1009. PubMed ID: 21374800 [Abstract] [Full Text] [Related]
18. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E. Carcinogenesis; 2006 Apr 31; 27(4):811-9. PubMed ID: 16280330 [Abstract] [Full Text] [Related]
19. Sulforaphane and its metabolite mediate growth arrest and apoptosis in human prostate cancer cells. Chiao JW, Chung FL, Kancherla R, Ahmed T, Mittelman A, Conaway CC. Int J Oncol; 2002 Mar 31; 20(3):631-6. PubMed ID: 11836580 [Abstract] [Full Text] [Related]
20. Prostate cancer chemoprevention by sulforaphane in a preclinical mouse model is associated with inhibition of fatty acid metabolism. Singh KB, Kim SH, Hahm ER, Pore SK, Jacobs BL, Singh SV. Carcinogenesis; 2018 May 28; 39(6):826-837. PubMed ID: 29668854 [Abstract] [Full Text] [Related] Page: [Next] [New Search]